Urinary Incontinence in Women Over 45: Causes and Treatment
For women over 45 with urinary incontinence, treatment should begin with pelvic floor muscle training (PFMT) for stress incontinence, bladder training for urgency incontinence, or both combined for mixed incontinence—these non-pharmacologic approaches are first-line because they improve continence rates and quality of life with minimal adverse effects. 1
Understanding the Causes
Women over 45 experience urinary incontinence at high rates—44-57% in middle-aged/postmenopausal women and up to 75% in elderly women 1. The condition is dramatically underreported, with at least half of affected women never mentioning it to their physician 1.
Key causative factors include:
- Pelvic floor trauma from vaginal delivery
- Menopause-related changes
- Prior hysterectomy
- Obesity
- Urinary tract infections
- Functional/cognitive impairment
- Chronic cough and constipation 1
Critical initial step: Identify and manage reversible causes including urinary tract infections, metabolic disorders, excess fluid intake, delirium, and medications that worsen incontinence 1.
Types of Incontinence
Stress incontinence: Urine leaks with physical exertion (coughing, laughing, sneezing) due to urethral sphincter failure 1
Urgency incontinence: Involuntary loss with sudden compelling urge to void 1
Mixed incontinence: Combination of both stress and urgency symptoms 1
Treatment Algorithm by Type
For Stress Incontinence
First-line: Pelvic floor muscle training (Kegel exercises) - this increases continence rates and improves quality of life 1. PFMT can include biofeedback using vaginal EMG probes for visual feedback on proper muscle contraction 1.
Second consideration: If obese, weight loss and exercise (strong recommendation, moderate-quality evidence) 1
Avoid: Systemic pharmacologic therapy—standard medications used for urgency incontinence are ineffective for stress incontinence 1. Note that vaginal estrogen formulations improved stress incontinence, but transdermal estrogen patches worsened it 1.
Surgical options: If conservative measures fail, mid-urethral slings are the most common surgical procedure 2, 3
For Urgency Incontinence
First-line: Bladder training—behavioral therapy that extends time between voiding 1. This improved urgency incontinence as a standalone treatment; adding PFMT to bladder training did not provide additional benefit for urgency incontinence specifically 1.
Second-line (if bladder training unsuccessful): Pharmacologic treatment 1. Choose medications based on tolerability, adverse effect profile, ease of use, and cost—not efficacy, as most drugs are similarly effective 1.
Effective medications include:
- Antimuscarinics: oxybutynin, tolterodine, darifenacin, solifenacin, fesoterodine, trospium
- β3-adrenergic agonists: mirabegron (associated with fewer anticholinergic side effects) 1
Important caveat: Tolterodine and oxybutynin have equal benefits, but tolterodine causes fewer harms 1. Common adverse effects include dry mouth, constipation, and blurred vision for antimuscarinics; nasopharyngitis and gastrointestinal issues for mirabegron 1. Poor adherence is common due to adverse effects 1.
Third-line interventions (if medications fail):
- OnabotulinumtoxinA bladder injections
- Percutaneous tibial nerve stimulation
- Sacral neuromodulation 3
For Mixed Incontinence
First-line: PFMT combined with bladder training—this combination improved continence and incontinence symptoms in women with mixed incontinence 1
Special Considerations for Women Over 45
Vulnerable populations requiring particular attention include women aged >65 years, nursing home residents, and those receiving Medicare home care services 1.
Quality of life impact: Urinary incontinence strongly associates with depression, sexual dysfunction, poor sleep, and reduced productivity 4. Treatment yields high patient satisfaction and quality-of-life improvements 5.
Cost-effectiveness: Nonpharmacologic management (PFMT, bladder training) is effective, has few adverse effects, and is cheaper than pharmacologic therapies 1. The condition accounts for approximately $19.5 billion in annual U.S. spending and 6% of nursing home admissions for elderly women 1.
Common Pitfalls to Avoid
- Don't skip the history: Clinicians must actively ask specific questions about onset, symptoms, and frequency—patients won't volunteer this information 1
- Don't use systemic medications for stress incontinence: They don't work 1
- Don't add PFMT to bladder training for pure urgency incontinence: Bladder training alone is sufficient 1
- Don't choose pharmacologic agents based on efficacy: They're all similarly effective; choose based on side effect profile and cost 1
- Don't use transdermal estrogen: It worsens incontinence, though vaginal estrogen may help stress incontinence 1